Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China

References

• Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst. 1995;87:796–802. PMID: 7791229.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65. PMID:11919208. PMCID: PMC1769629.
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27. doi:10.1056/NEJMoa021641. PMID:12571259.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107. PMID:21296855.
   PubMed Web of Science ®Google Scholar
• Wen C. China’s plans to curb cervical cancer. Lancet Oncol. 2005;6:139–41. doi:10.1016/S1470-2045(05)01761-4. PMID: 15737830.
   PubMed Web of Science ®Google Scholar
• Kim K, Zang R, Choi S-C, Ryu S-Y, Jae WK. Current status of gynecological cancer in China. J Gynecol Oncol. 2009 Jun;20(2):72–76. doi:10.3802/jgo.2009.20.2.72. PMID:19590717. PMCID: PMC2705001.
   PubMed Web of Science ®Google Scholar
• Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Annals Oncol. 2012 Oct;23(10):2755–62. doi:10.1093/annonc/mds069. PMID: 22492700.
   PubMed Web of Science ®Google Scholar
• Mijit F, Ablimit T, Abduxkur G, Abliz* G. Distribution of human papillomavirus (HPV)genotypes detected by routine pap smear in Uyghur-Muslim Women from Karasay Township Hotan (Xinjiang, China). J Med Virol PMID: 26081269. PMCID: PMC5033003. 2015;87:1960–65. doi:10.1002/jmv.24240.
   PubMed Web of Science ®Google Scholar
• Rong Wang, Xiao-lei Guo, G. Bea. A. Wisman, Ed Schuuring, Wen-feng Wang, Zheng-yu Zeng, Hong Zhu, Shang-wei Wu. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015 Jul 4;15:257. doi:10.1186/s12879-015-0998-5. PMID: 26142044.PMCID: PMC4491249.
   PubMed Web of Science ®Google Scholar
• Assoumou Z, Ndjoyi Mbiguino A, Mabika Mabika B, Nguizi Ogoula S, El Mzibri M, Khattabi A, Ennaji MM. Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agent Cancer. 2016;11:2. doi:10.1186/s13027-016-0046-0.
   PubMed Web of Science ®Google Scholar
• Smith, Krashias AM, Smouse SL, Tau NP, Bamford C, Moodley VM, Jacobs C, McCarthy KM, Lourens A, Keddy KH. HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities. BMC Infect Dis. 2017;17:346. doi:10.1186/s12879-017-2439-0.
   PubMed Web of Science ®Google Scholar
• Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen O-E, Olsson S-E, Høye J, Steinwall M, Riis-Johannessen G, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 2006;95:1459–66. doi:10.1038/sj.bjc.6603469. PMID: 17117182. PMCID: PMC2360730.
   PubMed Web of Science ®Google Scholar
• Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli MCM, Jenkins D, Schuind A, Costa CSA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet. 2006;367:1247–55. doi:10.1016/S0140-6736(06)68439-0. PMID: 16631880.
   PubMed Web of Science ®Google Scholar
• Kirby T. FDA approves new upgraded Gardasil 9. Lancet Oncol. 2015;16:e56. doi:10.1016/S1470-2045(14)71191-X. PMID: 25532625.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst . 2015 Apr 29;107(6):djv086. doi:10.1093/jnci/djv086.
   PubMedGoogle Scholar
• Human papillomavirus vaccines: WHO position paper, May 2017. PMID:28596091. DOI:10.1016/j.vaccine.2017.05.069
   Google Scholar
• Zhou H-L, Zhang W, Zhang C-J, Wang S-M, Duan Y-C, Wang J-X, Yang H, Wang X-Y. Prevalence and distribution of humanpapillomavirus genotypes in Chinese women between 1991 and 2016: A systematicreview. J Infect. 2018. doi:10.1016/j.jinf.2018.02.008. pii: S0163-4453(18)30061-6. PMID: 29477803.
   Web of Science ®Google Scholar
• Huh WK, Joura EA, Giuliano AR, Iversen O-E, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safetyanalyses of a nine-valent human papillomavirus vaccine in women aged 16–26years: final analyses of a randomised, double-blind trial. Lancet. 2017;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4. PMID: 28886907
   PubMed Web of Science ®Google Scholar
• Qiu-Xiang Xu, Zhang ZY. High-risk human papillomavirus genotypes incervical lesions and vaccination challenges in China. Asian Pac J Cancer Prev. 2015;16:2193–97. PMID: 25824736.
   PubMedGoogle Scholar
• Tao G, Yaling G, Zhan G, Pu L, Miao H. Human papillomavirus genotype distributionamong HPV-positive women in Sichuan province, Southwest China. Arch Virol. 2018;163(1):65–72. doi:10.1007/s00705-017-3556-1. PMID: 28983744
   PubMed Web of Science ®Google Scholar
• Meloni A, Pilia R, Campagna M, Usai A, Masia G, Caredda V, Coppola RC. Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities. J Public Health Res. 2014;3:157. doi:10.4081/jphr.2014.157.
   PubMedGoogle Scholar
• Simanaviciene V, Gudleviciene Z, Popendikyte V, Dekaminaviciute D, Stumbryte A, Rubinaite V, Zvirbliene A. Studies on the prevalence of oncogenic HPV types among Lithuanian women with cervical pathology. J Med Virol. 2015;87:461–71. doi:10.1002/jmv.24073.
   PubMed Web of Science ®Google Scholar
• Krashias G, Koptides D, Christodoulou C, Bamford C, Moodley VM, Jacobs C, McCarthy KM, Lourens A, Keddy KH. HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities. BMC Infect Dis. 2017;17:346. doi:10.1186/s12879-017-2439-0.
   PubMed Web of Science ®Google Scholar
• Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One . 2014 Mar 17;9(3):e91761. doi:10.1371/journal.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsague′ X, Ferrer E, Bosch FX, de Sanjose′ S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010 Dec 15;202(12):1789–99. doi:10.1086/657321.
   PubMed Web of Science ®Google Scholar
• Althoff KN, Paul P, Burke AE, Viscidi R, Sangaramoorthy M, Gravitt PE. Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. J Women’s Health. 2009 Sep;18(9):1341–46. doi:10.1089/jwh.2008.1223.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin H-R, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–56. doi:10.1016/S1470-2045(10)70230-8.
   PubMed Web of Science ®Google Scholar
• Kantathavorn N, Mahidol C, Sritana N, Sricharunrat T, Phoolcharoen N, Auewarakul C, Teerayathanakul N, Taepisitpong C, Saeloo S, Sornsamdang G, et al. Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infect Agent Cancer. 2015;10 article 7. doi:10.1186/s13027-015-0001-5.
   PubMed Web of Science ®Google Scholar
• Zhang C, Park J-S, Magdalena G, Hibbitts S, Palefsky JM, Konno R, Smith-McCune KK, Giovannelli L, Chu T-Y, Picconi MA, et al. Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages. J Infect Dis. 2014;210(10):1600–04. doi:10.1093/infdis/jiu310.
   PubMed Web of Science ®Google Scholar
• Panotopoulou E, Tserkezoglou A, Kouvousi M, Tonusin S, Phan TG, Okitsu S, Ushijima H. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women. J Med Virol. 2007;79:1898–905. doi:10.1002/jmv.21025.
   PubMed Web of Science ®Google Scholar
• Molano M, Van Den Brule A, Plummer M, Weiderpass E,  Posso H, Arslan A, Meijer CJ, Muñoz N, Franceschi S. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158:486–94. doi:10.1093/aje/kwg171. PMID:12936904.
   PubMed Web of Science ®Google Scholar
• Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM, Stram DO, Henderson BE, Kolonel LN, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–59. doi:10.1002/ijc.27485.
   PubMed Web of Science ®Google Scholar
• Dickson EL, Vogel RI, Geller MA, Downs LS Jr. Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65. Gynecol Oncol. 2014;133:405–08. doi:10.1016/j.ygyno.2014.03.552.
   PubMed Web of Science ®Google Scholar
• Moga MA, Irimie M, Oanta A, Pascu A, Burtea V. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov. Romania. Asian Pac J Cancer Prev. 2014;15:6887–92. PMID: 25169541.
   PubMedGoogle Scholar
• Lina Wang, Pengyan Wang, Yan Ren, Jingyun Du, Jianjun Jiang, Xuesong Jia, Chuangfu Chen, Yuanzhi Wang. Prevalence of high-risk human papillomavirus (HR-HPV) genotypes and multiple infections in cervical abnormalities from Northern Xinjiang, China. PLoS One. 2016 August 5. doi:10.1371/journal.pone.0160698.
   Web of Science ®Google Scholar
• Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomark Prev. 2005;14:1157–64. doi:10.1158/1055-9965.EPI-04-0812.
   PubMed Web of Science ®Google Scholar
• You W, Li S, Du R, Zheng J, Shen A. Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening. Exp Ther Med. 2018;15:412–18. doi:10.3892/etm.2017.5357.
   PubMed Web of Science ®Google Scholar
• Yuanyuan Wang, Shaohong Wang, Jinhui Shen, Yanyan Peng, Lechuan Chen, Ruiqin Mai, Guohong Zhang. Genotype distribution of human papillomavirus among women with cervical cytological abnormalities or invasive squamous cell Carcinoma in a high-incidence area of esophageal carcinoma in China. Biomed Res Int. 2016;2016:1256384. doi:10.1155/2016/1256384.
   PubMed Web of Science ®Google Scholar
• Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. J Am Med Assoc. 2002 Apr 24;287(16):2114–19. PMID:11966386.
   PubMed Web of Science ®Google Scholar